Literature DB >> 7934112

Chronic disease of the ascending aorta. Surgical treatment and long-term results.

F Jault1, P Nataf, A Rama, M Fontanel, E Vaissier, A Pavie, V Bors, C Cabrol, I Gandjbakhch.   

Abstract

Between January 1979 and December 1991, we operated on 339 patients for chronic disease of the ascending aorta. The operation was elective in all. Endocarditis and its sequelae have been excluded. Thirty-one patients had a previous operation on the ascending aorta or the aortic valve; 268 patients had aneurysms of the ascending aorta without dissection; 72 had chronic aortic dissections, of whom 33 had a preexistent aneurysm. The patients included 272 men and 67 women. Mean age was 53.58 +/- 7 years. Eight percent of the patients had clinical stigmata of Marfan's disease. A tubular graft replacement was used in 7 patients, a tubular graft and valve replacement in 72 patients, and a composite valve graft replacement with reattachment of the coronary arteries using a 8 mm Dacron graft was performed in 260 patients. Concomitant procedures were used in 74 patients: coronary artery bypass grafts in 25, mitral valve replacement in 9, and aortic arch reconstruction in 40. The 30-day mortality rate was 7.6% (n = 26). For the whole group, multivariate analysis using stepwise logistic regression showed that operative risk factors were concomitant coronary artery bypass grafting, age (increased), aortic valve regurgitation, and previous cardiac surgery. Follow-up was conducted in 303 patients, and risk factors for late mortality were studied. Long-term survival was 59.6% +/- 3.7% at 9 years. It was 67% +/- 3.5% at 9 years for patients without aortic arch reconstruction and 56% +/- 4.5% for patients with aortic arch reconstruction (p = 0.0018). Reoperation was needed in 14 patients. Actuarial freedom from reoperation was 90% +/- 0.2% at 9 years for all the patients. Only one patient with composite valve graft replacement and reattachment of the coronary arteries had required reoperation for problems related to this procedure. This technique is used routinely by our team, especially in patients with large chronic aneurysms, dissected or not, and in those who had previous operations. The long-term results are good.

Entities:  

Mesh:

Year:  1994        PMID: 7934112

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  6 in total

Review 1.  Dilation of the thoracic aorta: medical and surgical management.

Authors:  P Nataf; E Lansac
Journal:  Heart       Date:  2006-09       Impact factor: 5.994

2.  Risk factors for prophylactic proximal aortic replacement in the current era.

Authors:  Takashi Kunihara; Diana Aicher; Mitsuru Asano; Hiroaki Takahashi; Dierk Heimann; Fumihiro Sata; Hans-Joachim Schäfers
Journal:  Clin Res Cardiol       Date:  2014-01-24       Impact factor: 5.460

3.  The effect of proximal anastomosis on the expansion rate of a dilated ascending aorta in coronary artery bypass surgery: a prospective study.

Authors:  Ahmet Yavuz Balci; Unsal Vural; Rezan Aksoy; M Fatih Özdemir; Seçkin Satilmiş; Mehmet Kizilay; Mutlu Şenocak; Huseyin Şaşkin; Ilyas Kayacioğlu; Ibrahim Yekeler
Journal:  Cardiovasc J Afr       Date:  2016-08-22       Impact factor: 1.167

4.  Midterm follow up in patients with reduction ascending aortoplasty.

Authors:  Arndt H Kiessling; Eva Odwody; Alexandra Miskovic; Ulrich A Stock; Andreas Zierer; Anton Moritz
Journal:  J Cardiothorac Surg       Date:  2014-07-05       Impact factor: 1.637

5.  Reoperative Aortic Root Replacement in Patients with Previous Aortic Root or Aortic Valve Procedures.

Authors:  Byung Kwon Chong; Sung-Ho Jung; Suk Jung Choo; Cheol Hyun Chung; Jae Won Lee; Joon Bum Kim
Journal:  Korean J Thorac Cardiovasc Surg       Date:  2016-08-05

6.  Myocardial ischemia 10 years after a modified Cabrol procedure in a 42-year-old patient with Marfan syndrome.

Authors:  Ya Wei Hsiao; Jiann Woei Huang
Journal:  BMC Cardiovasc Disord       Date:  2020-10-27       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.